Device type · MMI
Immunoassay Method, Troponin Subunit
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
MMI
Clinical Chemistry
Device class
Class II
FDA decisions since 2015
20
510(k), De Novo and PMA
Adverse event reports
1,031
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Immunoassay Method, Troponin Subunit
- Product code
- MMI
- Device class
- Class II
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1215
- Specialty
- Laboratory Medicine & Pathology
- FDA record
- Classification database entry for MMI
Latest FDA decisions
The 8 newest of 20 since 2015.
K253051 · Decided Jun 11, 2026 · 262 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
Ortho-Clinical Diagnostics, Inc.
K252393 · Decided Oct 29, 2025 · 90 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
- Access hsTnI510(k)
K243483 · Decided Aug 1, 2025 · 266 days after receipt
Device type: Immunoassay Method, Troponin Subunit (MMI) · Laboratory Medicine & Pathology
17 more FDA decisions with a free account
Reports received
1,031
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
1,009
98% of reports
Injury reports
22
2.1% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 69 | 8 | 0 | 0 |
| Jan 24 | 60 | 1 | 0 | 0 |
| Feb 24 | 77 | 1 | 0 | 0 |
| Mar 24 | 254 | 5 | 0 | 0 |
| Apr 24 | 73 | 0 | 0 | 0 |
| May 24 | 78 | 3 | 0 | 0 |
| Jun 24 | 59 | 1 | 0 | 0 |
| Jul 24 | 49 | 2 | 0 | 0 |
| Aug 24 | 45 | 0 | 0 | 0 |
| Sep 24 | 44 | 2 | 0 | 0 |
| Oct 24 | 56 | 2 | 0 | 0 |
| Nov 24 | 51 | 2 | 0 | 0 |
| Dec 24 | 56 | 0 | 0 | 0 |
| Jan 25 | 58 | 1 | 0 | 0 |
| Feb 25 | 41 | 0 | 0 | 0 |
| Mar 25 | 58 | 3 | 0 | 0 |
| Apr 25 | 64 | 2 | 0 | 0 |
| May 25 | 87 | 7 | 0 | 0 |
| Jun 25 | 64 | 1 | 0 | 0 |
| Jul 25 | 71 | 7 | 0 | 0 |
| Aug 25 | 44 | 5 | 0 | 0 |
| Sep 25 | 61 | 6 | 0 | 0 |
| Oct 25 | 64 | 8 | 0 | 0 |
| Nov 25 | 72 | 4 | 0 | 0 |
| Dec 25 | 87 | 3 | 0 | 0 |
| Jan 26 | 55 | 1 | 0 | 0 |
| Feb 26 | 73 | 1 | 0 | 0 |
| Mar 26 | 67 | 1 | 0 | 0 |
| Apr 26 | 93 | 0 | 0 | 0 |
| May 26 | 76 | 1 | 0 | 0 |
| Jun 26 | 66 | 1 | 0 | 0 |
| Jul 26 | 62 | 2 | 0 | 0 |
| Aug 26 | 72 | 2 | 0 | 0 |
| Sep 26 | 199 | 2 | 0 | 0 |
| Oct 26 | 87 | 4 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
- Abbott468
6 more in this ranking with a free account
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- High Test Results717
- Non Reproducible Results185
- False Positive Result174
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions820
- Insufficient Information72
- Chest Pain54
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-0727-2025 · Started Nov 18, 2024 · Posted by FDA Dec 20, 2024
Reason given: Beckman Coulter, Inc. is recalling their Access hsTnI assay, a medical device by correction. The reason for the recall is: high troponin antigen (>55,000 pg/mL) can contaminate an analyzers probe and cause inter-assay carryover due to insufficient washing. The contamination can cause a falsely elevated Access hsTnI...
Cause as FDA categorized it: Component design/selection
- VITROS Immunodiagnostic Products Troponin I ES Reagent PackOpen, Classified
Z-2357-2023 · Started Jun 5, 2023 · Posted by FDA Aug 8, 2023
Reason given: Reagent packs could potentially contain incorrect wells, which will generate incorrect, and potentially false negative, results.
Cause as FDA categorized it: Process control
- VITROS Immunodiagnostic Products Troponin I ES CalibratorsOpen, Classified
Z-2358-2023 · Started Jun 5, 2023 · Posted by FDA Aug 8, 2023
Reason given: Reagent packs could potentially contain incorrect wells, which will generate incorrect, and potentially false negative, results.
Cause as FDA categorized it: Process control
53 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.